Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor W Stone

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Journal of Autoimmunity|May 25, 2023
LAT1 enables T cell activation under inflammatory conditionsJoy Ogbechi, Helen L Wright, Stefan Balint, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2021
Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritisYi-Shu Huang, Wen-Yi Tseng, Felix I L Clanchy, et al.
Clinical Drug Investigation|August 1, 2025
Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled TrialsHoulin Hong, Jack Donlon, Martin Schaefer, et al.
Brain Sciences|January 8, 2025
Galantamine-Memantine Combination in the Treatment of Parkinson's Disease DementiaEmma D Frost, Swanny X Shi, Vishnu V Byroju, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Journal of Autoimmunity|May 25, 2023
LAT1 enables T cell activation under inflammatory conditionsJoy Ogbechi, Helen L Wright, Stefan Balint, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2021
Pharmacological modulation of T cell immunity results in long-term remission of autoimmune arthritisYi-Shu Huang, Wen-Yi Tseng, Felix I L Clanchy, et al.
Clinical Drug Investigation|August 1, 2025
Memantine for the Treatment of Primary Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Controlled TrialsHoulin Hong, Jack Donlon, Martin Schaefer, et al.
Brain Sciences|January 8, 2025
Galantamine-Memantine Combination in the Treatment of Parkinson's Disease DementiaEmma D Frost, Swanny X Shi, Vishnu V Byroju, et al.
Pageof 11